2021
Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors
Berkman A, Andersen C, Puthenpura V, Livingston J, Ahmed S, Cuglievan B, Hildebrandt M, Roth M. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors. Cancer Epidemiology 2021, 75: 102044. PMID: 34597882, PMCID: PMC8627460, DOI: 10.1016/j.canep.2021.102044.Peer-Reviewed Original ResearchConceptsLong-term survivalDLBCL survivorsLymphoma survivorsSurvival disparitiesDiffuse Large B-Cell Lymphoma SurvivorsNon-Hispanic black survivorsNon-Hispanic white survivorsWorse long-term survivalReduced long-term survivalEnd Results registryOverall survival patternsRace/ethnicityMedian followMale sexWhite survivorsOlder ageSurvivorsRacial disparitiesYoung adultsBlack survivorsSocioeconomic statusSurvivalSurvival patternsSexCurrent studyAssociation of Medicare and Medicaid Insurance Status with Increased Spine Surgery Utilization Rates
Benton J, Weiss B, Mowrey W, Yassari N, Wang B, De La Garza Ramos R, Gelfand Y, Castro-Rivas E, Puthenpura V, Yassari R, Yanamadala V. Association of Medicare and Medicaid Insurance Status with Increased Spine Surgery Utilization Rates. Spine 2021, 46: e939-e944. PMID: 33496542, DOI: 10.1097/brs.0000000000003968.Peer-Reviewed Original ResearchConceptsInsurance statusSpine surgeryMedicaid patientsSpine careRetrospective single-institution studyPrivate insuranceLogistic regressionMedicaid insurance statusMultivariable logistic regressionSingle-institution studyMultivariate logistic regressionPatient insurance statusConsecutive outpatientsTreatment recommendationsUninsured patientsWorse outcomesBACKGROUND DATAInclusion criteriaPatient's conditionPatientsSurgerySpine surgeonsNeurosurgical clinicSignificant associationSpine interventions
2016
Spinal cord glioblastoma: 25years of experience from a single institution
Yanamadala V, Koffie R, Shankar G, Kumar J, Buchlak Q, Puthenpura V, Frosch M, Gudewicz T, Borges L, Shin J. Spinal cord glioblastoma: 25years of experience from a single institution. Journal Of Clinical Neuroscience 2016, 27: 138-141. PMID: 26755453, DOI: 10.1016/j.jocn.2015.11.011.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedChemoradiotherapyCombined Modality TherapyDNA MethylationFemaleGlioblastomaHumansKarnofsky Performance StatusMaleMiddle AgedNeoplasm ProteinsNeoplasm Recurrence, LocalProto-Oncogene Proteins B-rafRecovery of FunctionSpinal Cord NeoplasmsSurvival AnalysisTreatment OutcomeTumor Suppressor Protein p53ConceptsHigh-grade spinal cord gliomasSpinal cord gliomasKarnofsky performance statusFunctional statusAmerican Spine Injury Association (ASIA) scorePost-operative functional statusPost-operative radiationSubtotal surgical resectionSubset of patientsTumor recurrence rateYear survival rateTargeted molecular therapiesHigh-grade gliomasAdjuvant chemotherapyPerformance statusSurgical resectionPrimary outcomeRecurrence rateSingle institutionExcellent survivalSpinal cordPatientsAssociation scoreGrade gliomasSurvival rate